Results 171 to 180 of about 9,317 (205)
Some of the next articles are maybe not open access.
A2B Adenosine Receptor Antagonists with Picomolar Potency
Journal of Medicinal Chemistry, 2019The A2B adenosine receptor (A2BAR) was proposed as a novel target for the (immuno)therapy of cancer since A2BAR blockade results in antiproliferative, antiangiogenic, antimetastatic, and immunostimulatory effects. In this study, we explored the structure-activity relationships of xanthin-8-yl-benzenesulfonamides mainly by introducing a variety of ...
Jie Jiang +9 more
openaire +2 more sources
Discovery of oxazole-based PDE4 inhibitors with picomolar potency
Bioorganic & Medicinal Chemistry Letters, 2012Optimization of oxazole-based PDE4 inhibitors has led to the discovery of a series of quinolyl oxazoles, with 4-benzylcarboxamide and 5-α-aminoethyl groups which exhibit picomolar potency against PDE4. Selectivity profiles and in vivo biological activity are also reported.
Rongze, Kuang +19 more
openaire +2 more sources
Discovery of CC Chemokine Receptor-3 (CCR3) Antagonists with Picomolar Potency
Journal of Medicinal Chemistry, 2005Starting with our previously described(20) class of CC chemokine receptor-3 (CCR3) antagonist, we improved the potency by replacing the phenyl linker of 1 with a cyclohexyl linker and by replacing the 4-benzylpiperidine with a 3-benzylpiperidine. The resulting compound, 32, is a potent and selective antagonist of CCR3.
George V, De Lucca +23 more
openaire +2 more sources
ChemInform Abstract: Discovery of Oxazole‐Based PDE4 Inhibitors with Picomolar Potency.
ChemInform, 2012AbstractA series of quinolyloxazoles with 4‐benzylcarboxamide and 5‐α‐aminoethyl groups, which show picomolar potency against PDE4, is discovered.
Rongze Kuang, et al. et al.
openaire +1 more source
Bioorganic & Medicinal Chemistry Letters, 2003
A biaryl pyridylfuran P(3) substituent on the hydroxyethylene isostere scaffold affords HIV protease inhibitors (PI's) with picomolar (IC(50)) potency against the protease enzymes from PI-resistant HIV-1 strains. Inclusion of a gem-dimethyl substituent afforded compound 3 with 100% oral bioavailability (dogs) and more than double the t(1/2) of ...
Joseph L, Duffy +12 more
openaire +2 more sources
A biaryl pyridylfuran P(3) substituent on the hydroxyethylene isostere scaffold affords HIV protease inhibitors (PI's) with picomolar (IC(50)) potency against the protease enzymes from PI-resistant HIV-1 strains. Inclusion of a gem-dimethyl substituent afforded compound 3 with 100% oral bioavailability (dogs) and more than double the t(1/2) of ...
Joseph L, Duffy +12 more
openaire +2 more sources
Bioorganic & Medicinal Chemistry Letters, 2003
Transposition of the pyridyl nitrogen from the P(3) substituent to the P(1)' substituent in HIV-1 protease inhibitors (PI) affords compounds such as 3 with an improved inhibitory profile against multiple P450 isoforms. These compounds also displayed increased potency, with 3 inhibiting viral spread (CIC(95)) at
Joseph L, Duffy +12 more
openaire +2 more sources
Transposition of the pyridyl nitrogen from the P(3) substituent to the P(1)' substituent in HIV-1 protease inhibitors (PI) affords compounds such as 3 with an improved inhibitory profile against multiple P450 isoforms. These compounds also displayed increased potency, with 3 inhibiting viral spread (CIC(95)) at
Joseph L, Duffy +12 more
openaire +2 more sources
Biochemical and Biophysical Research Communications, 1987
The effect of CGRP on [14C]-aminopyrine accumulation in isolated parietal cell preparations from guinea-pig fundic mucosa was studied. Parietal cells consisted of 60% of the preparations. [14C]-Aminopyrine accumulation was used as an index of physiological response of parietal cells to secretagogues.
Y, Umeda, T, Okada
openaire +2 more sources
The effect of CGRP on [14C]-aminopyrine accumulation in isolated parietal cell preparations from guinea-pig fundic mucosa was studied. Parietal cells consisted of 60% of the preparations. [14C]-Aminopyrine accumulation was used as an index of physiological response of parietal cells to secretagogues.
Y, Umeda, T, Okada
openaire +2 more sources
Bioorganic & Medicinal Chemistry Letters, 2012
We previously disclosed tricylic, 6-carboxylic acid-bearing 4-quinolones as GSK-3β inhibitors. Herein we discuss the optimization of this series to yield a series of more potent 6-nitrile analogs with insignificant anti-microbial activity. Finally, kinase profiling indicated that members of this class were highly specific GSK-3 inhibitors.
Bei, Li +14 more
openaire +2 more sources
We previously disclosed tricylic, 6-carboxylic acid-bearing 4-quinolones as GSK-3β inhibitors. Herein we discuss the optimization of this series to yield a series of more potent 6-nitrile analogs with insignificant anti-microbial activity. Finally, kinase profiling indicated that members of this class were highly specific GSK-3 inhibitors.
Bei, Li +14 more
openaire +2 more sources
ChemInform, 2003
AbstractFor Abstract see ChemInform Abstract in Full Text.
Joseph L. Duffy, et al. et al.
openaire +1 more source
AbstractFor Abstract see ChemInform Abstract in Full Text.
Joseph L. Duffy, et al. et al.
openaire +1 more source
Bioorganic & Medicinal Chemistry Letters, 2005
AbstractFor Abstract see ChemInform Abstract in Full Text.
Gilles, Tamagnan +6 more
openaire +2 more sources
AbstractFor Abstract see ChemInform Abstract in Full Text.
Gilles, Tamagnan +6 more
openaire +2 more sources

